Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials
Background The standard of care for operable, stage I, non-small-cell lung cancer (NSCLC)
is lobectomy with mediastinal lymph node dissection or sampling. Stereotactic ablative …
is lobectomy with mediastinal lymph node dissection or sampling. Stereotactic ablative …
Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified …
…, SH Lin, MS O'Reilly, MD Jeter, PA Balter… - The Lancet …, 2021 - thelancet.com
Background A previous pooled analysis of the STARS and ROSEL trials showed higher
survival after stereotactic ablative radiotherapy (SABR) than with surgery for operable early-…
survival after stereotactic ablative radiotherapy (SABR) than with surgery for operable early-…
Quality assurance for image‐guided radiation therapy utilizing CT‐based technologies: a report of the AAPM TG‐179
Purpose: Commercial CT‐based image‐guided radiotherapy (IGRT) systems allow widespread
management of geometric variations in patient setup and internal organ motion. This …
management of geometric variations in patient setup and internal organ motion. This …
Assessing respiration-induced tumor motion and internal target volume using four-dimensional computed tomography for radiotherapy of lung cancer
HH Liu, P Balter, T Tutt, B Choi, J Zhang… - International Journal of …, 2007 - Elsevier
Purpose: To assess three-dimensional tumor motion caused by respiration and internal
target volume (ITV) for radiotherapy of lung cancer. Methods and Materials: Respiration-induced …
target volume (ITV) for radiotherapy of lung cancer. Methods and Materials: Respiration-induced …
[HTML][HTML] Delta-radiomics features for the prediction of patient outcomes in non–small cell lung cancer
Radiomics is the use of quantitative imaging features extracted from medical images to
characterize tumor pathology or heterogeneity. Features measured at pretreatment have …
characterize tumor pathology or heterogeneity. Features measured at pretreatment have …
Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non–small-cell lung cancer
JY Chang, PA Balter, L Dong, Q Yang, Z Liao… - International Journal of …, 2008 - Elsevier
PURPOSE: To evaluate the efficacy and adverse effects of image-guided stereotactic body
radiation therapy (SBRT) in centrally/superiorly located non–small-cell lung cancer (NSCLC). …
radiation therapy (SBRT) in centrally/superiorly located non–small-cell lung cancer (NSCLC). …
Stereotactic ablative radiation therapy for centrally located early stage or isolated parenchymal recurrences of non-small cell lung cancer: how to fly in a “no fly zone”
…, PK Allen, N Rebueno, DR Gomez, P Balter… - International Journal of …, 2014 - Elsevier
Purpose We extended our previous experience with stereotactic ablative radiation therapy (SABR;
50 Gy in 4 fractions) for centrally located non-small cell lung cancer (NSCLC); …
50 Gy in 4 fractions) for centrally located non-small cell lung cancer (NSCLC); …
An evaluation of three commercially available metal artifact reduction methods for CT imaging
…, JR Kerns, JL Nute, X Liu, PA Balter… - Physics in Medicine …, 2015 - iopscience.iop.org
Three commercial metal artifact reduction methods were evaluated for use in computed
tomography (CT) imaging in the presence of clinically realistic metal implants: Philips O-MAR, …
tomography (CT) imaging in the presence of clinically realistic metal implants: Philips O-MAR, …
Can radiomics features be reproducibly measured from CBCT images for patients with non‐small cell lung cancer?
Purpose: Increasing evidence suggests radiomics features extracted from computed
tomography (CT) images may be useful in prognostic models for patients with nonsmall cell lung …
tomography (CT) images may be useful in prognostic models for patients with nonsmall cell lung …
Stereotactic ablative radiotherapy with or without immunotherapy for early-stage or isolated lung parenchymal recurrent node-negative non-small-cell lung cancer: an …
…, RJ Mehran, AA Vaporciyan, SG Swisher, PA Balter… - The Lancet, 2023 - thelancet.com
Background Stereotactic ablative radiotherapy (SABR) is the standard treatment for
medically inoperable early-stage non-small-cell lung cancer (NSCLC), but regional or distant …
medically inoperable early-stage non-small-cell lung cancer (NSCLC), but regional or distant …